Leerink Partners Maintains Boundless Bio(BOLD.US) With Buy Rating
Boundless Bio (BOLD.US) was first covered by Leerink Partners, which gave it an superior market rating and a target price of $25.00.
Boundless Bio Analyst Ratings
Analysts' Opinions Are Mixed on These NA Stocks: Boundless Bio Inc. (BOLD) and Solventum Corporation (SOLV)
Boundless Bio (BOLD.US) was first covered by Piper Sandler, which gave it an increase rating, with a target price of $20.00.
Boundless Bio Analyst Ratings
Piper Sandler Initiates Coverage On Boundless Bio With Overweight Rating, Announces Price Target of $20
No Data
No Data